Suppr超能文献

替瑞利克斯的聚乳酸-羟基乙酸共聚物-聚乙二醇微球:聚合物类型对微球特性及替瑞利克斯体外释放的影响

PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release.

作者信息

Mallardé Delphine, Boutignon François, Moine Fabien, Barré Edith, David Sandrine, Touchet Hélène, Ferruti Paolo, Deghenghi Romano

机构信息

Europeptides, 9 av du Marais, 95108, Argenteuil, France.

出版信息

Int J Pharm. 2003 Aug 11;261(1-2):69-80. doi: 10.1016/s0378-5173(03)00272-2.

Abstract

Teverelix microspheres were produced by coacervation using a new type of poly(ester-carbonates) made of block copolymers of poly(lactic-glycolic acid) (PLGA) and poly(ethylene glycol) (PEG). Five different PLGA-PEG copolymers and one PLGA were used. The 'stability window' has been determined for all polymers. It varied depending on the molecular weight and the weight percentage of PEG. With increasing core loading (from 9.4 to 34.2%), the microparticle size increased from 10-50 to 5-1000 micrometer. The core loading did not have any influence on encapsulation yield, which remained above 80%. The influence of polymer type on microsphere characteristics was studied at two different core loadings: 9.4 and 28%. At a low core loading, the nature of the polymer had no influence on microsphere characteristics whereas at 28%, only PLGA-PEG copolymers gave acceptable microparticles in term of particle size. At 28%, the glass transition temperature (T(g)) of loaded particles was 1-8 degrees C higher than the T(g) of the corresponding polymer. Increasing the core loading increased teverelix release whereas polymer degradation was decreased. All microparticles made of PLGA-PEG copolymers showed a faster release of teverelix than PLGA-based microspheres, whatever the core loading. One PLGA-PEG was selected on the basis of in vitro release rate for further in vivo investigations.

摘要

使用由聚乳酸 - 乙醇酸共聚物(PLGA)和聚乙二醇(PEG)的嵌段共聚物制成的新型聚(酯 - 碳酸酯)通过凝聚法制备了替瑞利克斯微球。使用了五种不同的PLGA - PEG共聚物和一种PLGA。已确定了所有聚合物的“稳定窗口”。它随PEG的分子量和重量百分比而变化。随着核心载药量增加(从9.4%到34.2%),微粒尺寸从10 - 50微米增加到5 - 1000微米。核心载药量对包封率没有任何影响,包封率保持在80%以上。在两种不同的核心载药量(9.4%和28%)下研究了聚合物类型对微球特性的影响。在低核心载药量下,聚合物的性质对微球特性没有影响,而在28%时,就粒径而言,只有PLGA - PEG共聚物能得到可接受的微粒。在28%时,负载颗粒的玻璃化转变温度(T(g))比相应聚合物的T(g)高1 - 8摄氏度。增加核心载药量会增加替瑞利克斯的释放,而聚合物降解则减少。无论核心载药量如何,所有由PLGA - PEG共聚物制成的微球都比基于PLGA的微球显示出更快的替瑞利克斯释放。基于体外释放速率选择了一种PLGA - PEG进行进一步的体内研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验